{"database": "lobbying", "table": "lobbying_activities", "rows": [[1659411, "b763e360-aad7-4fab-bf84-7a7b6e29ff82", "Q1", "WILLIAMS AND JENSEN, PLLC", 41454, "SHIRE PHARMACEUTICALS LLC FORMERLY KNOWN AS SHIRE REGENERATIVE MEDICINE", 2015, "first_quarter", "MMM", "Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB);  potential drug industry issues in H.R. 2 the Medicare Access and CHIP Reauthorization Act.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2015-04-13T14:40:45.267000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1659411"], "units": {}, "query_ms": 9.91389001137577, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}